NEW YORK (360Dx) – A single-cell capture device under development at the Massachusetts Institute of Technology and National Chiao Tung University may lead to a point-of-care diagnostic test for infectious diseases or cancers that costs less than $5 and produces results in less than 10 minutes.

A proof-of-concept prototype of the test relies on oxide functional groups from graphene oxide along with a novel configuration to capture and measure cells from whole blood.